RILMOBLI
LIVE

Serial Number

99446203

Owner

Sanofi

Attorney

Alexandra Kochian

Filing Date

Oct 16, 2025

Add to watchlist:

No watchlists yet
View on USPTO

RILMOBLI Trademark

Serial Number: 99446203

RILMOBLI is a trademark filed by Sanofi on October 16, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Sanofi (13 trademarks)

Paris 75017 , FR

Entity Type: 03

Trademark Details

Filing Date

October 16, 2025

Registration Date

Not Registered

Published for Opposition

March 24, 2026

Goods & Services

Pharmaceutical preparations for the treatment and prevention of autoimmune, immune-mediated, immune-system related, inflammatory, and neurological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of rare autoimmune, rare immune-mediated, rare immune-system related, rare inflammatory, and rare neurological diseases and disorders

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 19, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 24, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 27, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 15, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 15, 2026 GNSL
SUSPENSION LETTER WRITTEN
Jan 15, 2026 CNSL
ASSIGNED TO EXAMINER
Jan 13, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 16, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2025 NWOS
NEW APPLICATION ENTERED
Oct 16, 2025 NWAP